Sepsis is a prevalent, deadly, yet often elusive condition in emergency departments worldwide. Despite growing recognition in significance of timely identification and guidelines-defined interventions for improvement of patients’ outcomes, diagnosing sepsis in large group of patients who present with mild and non-specific initial symptoms challenges both clinical gestalt and institutional protocols. The decades-long quest for definitive sepsis biomarkers remains largely unfulfilled and utilization of biomarkers varies widely across countries and institutions.
In this webinar, two world-recognized emergency medicine experts in sepsis, Dr. Tiffany Osborn from Washington University, St. Louis, MO and Dr. Pierre Hausfater from Sorbonne University, Paris, France will introduce and discuss a novel hematologic parameter, Monocyte Distribution Width (MDW), recently cleared by the FDA and European Authorities for sepsis detection in the Emergency Department. MDW is available as a part of CBC with Differential test which is already routinely utilized as an early screening test for a variety of the conditions. They will discuss:
• The current state of clinical evidence for MDW derived from the series of multicenter studies
• The practical implications of these results to the U.S. and European standards of sepsis care
Tiffany Osborn, MD, MPH, is triple boarded in emergency medicine, U.S. critical care and European critical care.
Professor Hausfater started his career as an internal medicine specialist focused on autoimmune and inflammatory diseases.